HLB Therapeutics Co.,Ltd. (KOSDAQ: 115450)

HLB Therapeutics Co.,Ltd. Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 19, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	853,094	331,362	365,136	378,914	776,711	773,154
Market Cap Growth	202.92%	-9.25%	-3.64%	-51.22%	0.46%	13.38%
Enterprise Value	864,664	315,400	359,858	380,861	785,426	791,163
Last Close Price	10690.00	4385.00	5410.63	6604.59	13629.26	14609.44
PS Ratio	14.09	6.16	8.61	8.69	18.09	13.11
PB Ratio	5.82	1.93	2.85	2.91	7.74	10.16
P/TBV Ratio	5.58	2.21	3.28	3.31	9.64	14.60
P/FCF Ratio	-	109.54	-	-	-	-
P/OCF Ratio	-	99.60	-	-	-	-
EV/Sales Ratio	15.64	5.87	8.49	8.74	18.30	13.42
EV/FCF Ratio	-214.78	104.26	-	-	-	-
Debt / Equity Ratio	0.12	0.06	0.41	0.39	0.13	0.64
Debt / FCF Ratio	-	3.31	-	-	-	-
Asset Turnover	0.27	0.28	0.22	0.28	0.33	0.48
Inventory Turnover	6.82	7.88	7.65	13.82	11.14	14.01
Quick Ratio	2.26	1.57	1.24	1.91	1.82	0.94
Current Ratio	3.40	1.86	1.36	2.00	2.06	1.03
Return on Equity (ROE)	-16.57%	-1.85%	-8.97%	-15.42%	-19.73%	-21.24%
Return on Assets (ROA)	-3.05%	-2.85%	-2.49%	-4.45%	-5.39%	-6.01%
Return on Capital (ROIC)	-3.30%	-3.06%	-2.60%	-4.70%	-5.90%	-6.90%
Earnings Yield	-3.70%	-0.69%	-3.11%	-4.54%	-2.18%	-2.12%
FCF Yield	-0.47%	0.91%	-3.34%	-3.19%	-1.51%	-0.79%
Buyback Yield / Dilution	-3.82%	-10.59%	-10.86%	-7.26%	-4.63%	-5.32%
Total Shareholder Return	-3.82%	-10.59%	-10.86%	-7.26%	-4.63%	-5.32%

Source: S&P Capital IQ. Standard template. Financial Sources.